Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 9 Lung Neoplasms 6 Carcinoma, Non-Small-Cell Lung 4 Prostatic Neoplasms 3 Barrett Esophagus 3 Stomach Neoplasms 2 Recurrence 2 Rectal Neoplasms 2 Pancreatic Neoplasms 2 Neoplasms 2 Multiple Pulmonary Nodules 2 Melanoma 2 Glioma 2 Colorectal Neoplasms 2 Adenocarcinoma of Lung 2 Triple Negative Breast Neoplasms 1 Thyroid Nodule 1 Thyroid Neoplasms 1 Spinal Fractures 1 Solitary Pulmonary Nodule 1 Smoking Cessation 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Phyllodes Tumor 1 Osteoporosis 1 Nevus 1 Neoplastic Cells, Circulating 1 Neoplasm Metastasis 1 Lymphoma, Follicular 1 Lung Diseases 1

Interventions

Gemcitabine 6 130-nm albumin-bound paclitaxel 4 S 1 (combination) 2 Radiosurgery 2 Oxaliplatin 2 Leucovorin 2 Fluorouracil 2 Electroporation 2 zimberelimab 1 surufatinib 1 Tomography, X-Ray Computed 1 Pancreatectomy 1 Irinotecan 1 Immunotherapy 1 Heavy Ion Radiotherapy 1 Endoscopy 1 Drug Therapy 1 Diagnostic Imaging 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Locally Advanced Pancreatic Cancer × Diagnostic Imaging × Clear all

NCT06944587 2025-04-25

NORPACT-3

Oslo University Hospital

Gastrointestinal

Locally Advanced Pancreatic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡